Devashish Saini, MD | |
1 Hospital Dr, Dco18.00, Ma202f, Columbia, MO 65212-0001 | |
(573) 882-8885 | |
(573) 884-4808 |
Full Name | Devashish Saini |
---|---|
Gender | Male |
Speciality | Surgery |
Location | 1 Hospital Dr, Columbia, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225235674 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 2007019035 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Devashish Saini, MD 1 Hospital Dr, Dco18.00, Ma202f, Columbia, MO 65212-0001 Ph: (573) 882-8885 | Devashish Saini, MD 1 Hospital Dr, Dco18.00, Ma202f, Columbia, MO 65212-0001 Ph: (573) 882-8885 |
News Archive
Californians with developmental disabilities who are cared for at state facilities are being put at risk by outdated policies and inadequate investigations of abuse, the state auditor's office said Tuesday. Allegations that residents have been raped, shot with stun guns and otherwise abused have not been acted on satisfactorily, auditors found. The California Department of Developmental Services cares for 1,480 severely disabled people in five facilities throughout the state (McGreevy, 7/9).
Kemin Foods, L.C. ("Kemin") and OmniActive Health Technologies, Inc. and OmniActive Health Technologies, Ltd. ("OmniActive") have reached an amicable settlement of their dispute.
Vaccinating infants against rotavirus also prevents serious disease in unvaccinated older children and adults, according to a study by the Centers for Disease Control and Prevention.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.
› Verified 6 days ago
Olivia Louise Bolles, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-4141 | |
Alice Lee, Surgery Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-5609 Fax: 573-884-6054 | |
Ioan-andrei Scumpu, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Mchaney Hall 404, Dco75.00, Columbia, MO 65212 Phone: 573-884-2000 | |
Marc L Miller, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 115 Business Loop 70 W, Columbia, MO 65203 Phone: 573-882-8454 Fax: 573-884-6054 | |
Dr. Mary Carr, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Brent W Miedema, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr # 617, Columbia, MO 65201 Phone: 573-814-6346 | |
Richard Smith, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Drive, Columbia, MO 65201 Phone: 573-884-4854 Fax: 573-884-6054 |